Abir L. Wahab

Université Paris Est
Creteil, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Anti-CD20 Discontinuation Versus Continuation in People Aged Over 50 With Non-Active Multiple Sclerosis.

Anti-CD20 Discontinuation Versus Continuation in People Aged Over 50 With Non-Active Multiple Sclerosis.

Journal: Annals of clinical and translational neurology

Published: June 12, 2026

Differences in Use of Disease-Modifying Therapies Between Patients With Late-Onset and Adult-Onset Relapsing-Remitting Multiple Sclerosis.

Differences in Use of Disease-Modifying Therapies Between Patients With Late-Onset and Adult-Onset Relapsing-Remitting Multiple Sclerosis.

Journal: Neurology

Published: May 05, 2026

Initial treatment choice for multiple sclerosis and prognosis at year 3 are associated with few poor prognosis factors.

Initial treatment choice for multiple sclerosis and prognosis at year 3 are associated with few poor prognosis factors.

Journal: Multiple sclerosis and related disorders

Published: February 14, 2026

Comparative effectiveness of ocrelizumab in subgroups of patients with multiple sclerosis: a multi-registry observational cohort study.

Comparative effectiveness of ocrelizumab in subgroups of patients with multiple sclerosis: a multi-registry observational cohort study.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: January 13, 2026

Preserving Neurological Function in People at High and Low Risk of Aggressive Multiple Sclerosis: An Observational Cohort Study.

Preserving Neurological Function in People at High and Low Risk of Aggressive Multiple Sclerosis: An Observational Cohort Study.

Journal: CNS drugs

Published: September 04, 2025

Therapeutic Management During Pregnancy and Relapse Risk in Women With Multiple Sclerosis.

Therapeutic Management During Pregnancy and Relapse Risk in Women With Multiple Sclerosis.

Journal: JAMA neurology

Published: August 04, 2025

Sex-Related Gap in the Use of Disease-Modifying Therapies in Multiple Sclerosis.

Sex-Related Gap in the Use of Disease-Modifying Therapies in Multiple Sclerosis.

Journal: Neurology

Published: July 30, 2025

Progression independent of relapse and MRI activity and treatment strategies in multiple sclerosis.

Progression independent of relapse and MRI activity and treatment strategies in multiple sclerosis.

Journal: Brain : a journal of neurology

Published: July 21, 2025

Use of Disease-Modifying Therapies in Patients With Late-Onset Multiple Sclerosis.

Use of Disease-Modifying Therapies in Patients With Late-Onset Multiple Sclerosis.

Journal: Neurology

Published: July 16, 2025

Target trial emulation to replicate randomised clinical trials using registry data in multiple sclerosis.

Target trial emulation to replicate randomised clinical trials using registry data in multiple sclerosis.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: May 16, 2025

Assessing the Risk of Relapse After In Vitro Fertilization in Women With Multiple Sclerosis.

Assessing the Risk of Relapse After In Vitro Fertilization in Women With Multiple Sclerosis.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: February 11, 2025

Comparative Study Between Cognitive Phenotypes of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Multiple Sclerosis.

Comparative Study Between Cognitive Phenotypes of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Multiple Sclerosis.

Journal: Diagnostics (Basel, Switzerland)

Published: January 03, 2025

Showing 1-12 of 34

Last Updated: 09/26/2026